MoneyWorks4Me

Alembic Pharmaceuticals informs about analyst meet

25 Nov 2022 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that the management of the Company shall be meeting analysts/investors through NBIE Virtual Investor Meeting hosted by Nirmal Bang Institutional Equities on 25th November, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..